These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29685920)

  • 1. Comment on 2018 American Academy of Neurology guidelines on disease-modifying therapies in MS.
    Corboy JR; Weinshenker BG; Wingerchuk DM
    Neurology; 2018 Jun; 90(24):1106-1112. PubMed ID: 29685920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Rae-Grant A; Day GS; Marrie RA; Rabinstein A; Cree BAC; Gronseth GS; Haboubi M; Halper J; Hosey JP; Jones DE; Lisak R; Pelletier D; Potrebic S; Sitcov C; Sommers R; Stachowiak J; Getchius TSD; Merillat SA; Pringsheim T
    Neurology; 2018 Apr; 90(17):777-788. PubMed ID: 29686116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Rae-Grant A; Day GS; Marrie RA; Rabinstein A; Cree BAC; Gronseth GS; Haboubi M; Halper J; Hosey JP; Jones DE; Lisak R; Pelletier D; Potrebic S; Sitcov C; Sommers R; Stachowiak J; Getchius TSD; Merillat SA; Pringsheim T
    Neurology; 2018 Apr; 90(17):789-800. PubMed ID: 29686117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.
    Montalban X; Gold R; Thompson AJ; Otero-Romero S; Amato MP; Chandraratna D; Clanet M; Comi G; Derfuss T; Fazekas F; Hartung HP; Havrdova E; Hemmer B; Kappos L; Liblau R; Lubetzki C; Marcus E; Miller DH; Olsson T; Pilling S; Selmaj K; Siva A; Sorensen PS; Sormani MP; Thalheim C; Wiendl H; Zipp F
    Eur J Neurol; 2018 Feb; 25(2):215-237. PubMed ID: 29352526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis.
    Marques VD; Passos GRD; Mendes MF; Callegaro D; Lana-Peixoto MA; Comini-Frota ER; Vasconcelos CCF; Sato DK; Ferreira MLB; Parolin MKF; Damasceno A; Grzesiuk AK; Muniz A; Matta APDC; Oliveira BES; Tauil CB; Maciel DRK; Diniz DS; Corrêa EC; Coronetti F; Jorge FMH; Sato HK; Gonçalves MVM; Sousa NAC; Nascimento OJM; Gama PDD; Domingues R; Simm RF; Thomaz RB; Morales RR; Dias RM; Apóstolos-Pereira SD; Machado SCN; Junqueira TF; Becker J
    Arq Neuropsiquiatr; 2018 Aug; 76(8):539-554. PubMed ID: 30231128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary and alternative medical therapies in multiple sclerosis--the American Academy of Neurology guidelines: a commentary.
    Yadav V; Narayanaswami P
    Clin Ther; 2014 Dec; 36(12):1972-1978. PubMed ID: 25467189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Farez MF; Correale J; Armstrong MJ; Rae-Grant A; Gloss D; Donley D; Holler-Managan Y; Kachuck NJ; Jeffery D; Beilman M; Gronseth G; Michelson D; Lee E; Cox J; Getchius T; Sejvar J; Narayanaswami P
    Neurology; 2019 Sep; 93(13):584-594. PubMed ID: 31462584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical use of off-label disease-modifying therapies for multiple sclerosis.
    Laurson-Doube J; Rijke N; Helme A; Baneke P; Banwell B; Viswanathan S; Hemmer B; Yamout B
    Mult Scler; 2021 Aug; 27(9):1403-1410. PubMed ID: 34304636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus recommendations on the management of multiple sclerosis patients in Argentina.
    Cristiano E; Rojas JI; Alonso R; Alvez Pinheiro A; Bacile EA; Balbuena ME; Barboza AG; Bestoso S; Burgos M; Cáceres F; Carnero Contentti E; Curbelo MC; Deri N; Fernandez Liguori N; Gaitán MI; Garcea O; Giunta D; Halfon MJ; Hryb JP; Jacobo M; Kohler E; Luetic GG; Maglio I; Martínez AD; Míguez J; Nofal PG; Patrucco L; Piedrabuena R; Rotta Escalante R; Saladino ML; Silva BA; Sinay V; Tkachuk V; Villa A; Vrech C; Ysrraelit MC; Correale J
    J Neurol Sci; 2020 Feb; 409():116609. PubMed ID: 31816524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology.
    Yadav V; Bever C; Bowen J; Bowling A; Weinstock-Guttman B; Cameron M; Bourdette D; Gronseth GS; Narayanaswami P
    Neurology; 2014 Mar; 82(12):1083-92. PubMed ID: 24663230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Haselkorn JK; Hughes C; Rae-Grant A; Henson LJ; Bever CT; Lo AC; Brown TR; Kraft GH; Getchius T; Gronseth G; Armstrong MJ; Narayanaswami P
    Neurology; 2015 Nov; 85(21):1896-903. PubMed ID: 26598432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Wright S; Yadav V; Bever C; Bowen J; Bowling A; Weinstock-Guttman B; Cameron M; Bourdette D; Gronseth GS; Narayanaswami P
    Neurology; 2014 Oct; 83(16):1484-6. PubMed ID: 25313380
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted clinical audits immediately following the establishment of clinical practice guidelines for multiple sclerosis in 17 neurology departments: A pragmatic and collaborative study.
    Lairy G; Zephir H; Ouallet JC; Le Page E; Laplaud D; Bensa C; De Seze J
    Rev Neurol (Paris); 2015 May; 171(5):407-14. PubMed ID: 25912471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Social Media on Dissemination and Implementation of Clinical Practice Guidelines: A Longitudinal Observational Study.
    Narayanaswami P; Gronseth G; Dubinsky R; Penfold-Murray R; Cox J; Bever C; Martins Y; Rheaume C; Shouse D; Getchius TS
    J Med Internet Res; 2015 Aug; 17(8):e193. PubMed ID: 26272267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAN unveils new guidelines for MS disease-modifying therapy.
    Bittner S; Zipp F
    Nat Rev Neurol; 2018 Jul; 14(7):384-386. PubMed ID: 29895963
    [No Abstract]   [Full Text] [Related]  

  • 17. European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.
    Otero-Romero S; Lebrun-Frénay C; Reyes S; Amato MP; Campins M; Farez M; Filippi M; Hacohen Y; Hemmer B; Juuti R; Magyari M; Oreja-Guevara C; Siva A; Vukusic S; Tintoré M
    Eur J Neurol; 2023 Aug; 30(8):2144-2176. PubMed ID: 37293849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice guideline: Cervical and ocular vestibular evoked myogenic potential testing: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Fife TD; Colebatch JG; Kerber KA; Brantberg K; Strupp M; Lee H; Walker MF; Ashman E; Fletcher J; Callaghan B; Gloss DS
    Neurology; 2017 Nov; 89(22):2288-2296. PubMed ID: 29093067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment optimization in multiple sclerosis.
    Freedman MS; Patry DG; Grand'Maison F; Myles ML; Paty DW; Selchen DH;
    Can J Neurol Sci; 2004 May; 31(2):157-68. PubMed ID: 15198439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical recommendations for the process of proposing, planning and writing a neurological management guideline by EAN task forces.
    Leone MA; Keindl M; Schapira AH; Deuschl G; Federico A
    Eur J Neurol; 2015 Dec; 22(12):1505-10. PubMed ID: 26268048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.